Saikosaponin B2 Prevents Against BAP-induced Lungs Cancer in Mouse Model by Regulating Oxidative Stress / (Record no. 608895)

000 -LEADER
fixed length control field 01936nam a22001577a 4500
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 610
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Imran, Jannat
245 ## - TITLE STATEMENT
Title Saikosaponin B2 Prevents Against BAP-induced Lungs Cancer in Mouse Model by Regulating Oxidative Stress /
Statement of responsibility, etc. Jannat Imran
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Islamabad :
Name of producer, publisher, distributor, manufacturer SMME- NUST;
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Extent 83p.
Other physical details Soft Copy
Dimensions 30cm
500 ## - GENERAL NOTE
General note Cancer of the lungs is the second most frequent form of cancer overall and has the<br/>greatest mortality rate because to its severe pathological abnormalities. In lung cancer,<br/>abnormal cell proliferation causes the alveolar duct to clot. Lung cancer is difficult to<br/>treat due to its clinical and biological heterogeneity, which necessitates the development<br/>of new therapeutic approaches or the refinement of existing ones. To investigate this,<br/>saikosaponin b2 was administered to mice with lung cancer caused by B(a)P. (SSb2).<br/>BAP is considered a group one carcinogen by the International Agency for Research on<br/>Cancer (IARC). Therefore, B(a)P may play a role in producing lung cancer. Albino<br/>balb/c mice were given B(a)P on alternate days over a 4-week period to induce cancer,<br/>with DMBA given weekly to encourage tumor growth. Beginning in the third week,<br/>SSb2 was given daily for twenty days. The drug's potential anti-cancer effects were<br/>studied by examining hepatic biomarkers, lung histology, and oxidative stress indicators.<br/>Increases in SOD, CAT, GST, and GSH levels accompanied by decreases in MDA levels<br/>and enhanced B(a)P detoxification after SSb2 treatment, which also improved liver<br/>function. Histopathology data showed that as compared with the B(a)P alone group, SSb2<br/>reduced inflammation, membrane blebbing, and alveolar structure began returning to<br/>normal.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element MS Biomedical Sciences (BMS
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Supervisor : Dr. Adeeb Shehzad
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://10.250.8.41:8080/xmlui/handle/123456789/30889">http://10.250.8.41:8080/xmlui/handle/123456789/30889</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Thesis
Holdings
Withdrawn status Permanent Location Current Location Shelving location Date acquired Full call number Barcode Koha item type
  School of Mechanical & Manufacturing Engineering (SMME) School of Mechanical & Manufacturing Engineering (SMME) E-Books 04/19/2024 610 SMME-TH-782 Thesis
© 2023 Central Library, National University of Sciences and Technology. All Rights Reserved.